Berenberg analyst Luisa Hector lowered the firm’s price target on Roche to CHF 350 from CHF 380 and keeps a Buy rating on the shares.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RHHBY:
- European Commission approves label expansion of Roche’s Hemlibra to include people with moderate haemophilia A in the EU
- Jana Care, Roche collaborate to develop, distribute blood testing platform
- Vaccitech appoints Pelletier as Chief Scientific Officer
- Spark Therapeutics enters collaboration with Neurochase
- Roche launches COVID-19 PCR test to detect XBB.1.5 Omicron sub-variant